General
A New Alzheimer's Drug Just Hit a Major Milestone in a Human Clinical Trial
 

A New Alzheimer's Drug Just Hit a Major Milestone in a Human Clinical Trial

Shared by:

 
A new drug that targets toxic amyloid proteins in the brain - one of the main hallmarks of Alzheimer’s disease - has produced such promising results in a small clinical trial, it’s now being assessed in two larger trials involving 3,500 patients.
 
www.sciencealert.com
 
4 Nov 2016 - General
 
It is a good time for Merck for clearing Phase I clinical trials. The drug name not stated in the article, I will tell you. It is Verubecestat, a β-site amyloid precursor protein cleaving enzyme 1 (BACE1). Hopefully it has 66 percent chances to compl...
 (Total 72 words)
A new drug for treatment of Alzheimer's has cleared phase I clinical trials and has shown promising results in slowing down the progression of the disease. And if this drug makes it to the next level it could be the first treatment to enter the m...
 (Total 115 words)